Status:
COMPLETED
PROmyBETAappGame: a Study to Learn More About the Medication Usage & Patient Reported Outcomes Via the myBETAapp and to Find Out More About the Usage of Game Principles and Game Design Elements (Gamification) in Medical Care of Patients With Multiple Sclerosis Treated With Betaferon
Lead Sponsor:
Bayer
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18+ years
Brief Summary
In this study researchers wanted to learn more about the medication usage behavior among multiple sclerosis (MS) patients treated with Betaferon using the myBETAapp which includes the elements to what...
Detailed Description
The PROmyBETAappGame study was a mixed prospective and retrospective, non-interventional, observational cohort study
Eligibility Criteria
Inclusion
- Inclusion criteria
- Patients aged ≥ 18 years.
- Patients on treatment with Betaferon (every Betaferon box contains a "Mixject" number, which is a product specific number unrelated to the study. Only patients prescribed Betaferon for their MS will be able to use the myBETAapp and participate in the study).
- Patients must be using the myBETAapp.
- Electronic informed consent must be obtained.
- Exclusion criteria
- \- No exclusion criteria for participation in this study were defined.
Exclusion
Key Trial Info
Start Date :
February 20 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 2 2020
Estimated Enrollment :
79 Patients enrolled
Trial Details
Trial ID
NCT03808142
Start Date
February 20 2019
End Date
September 2 2020
Last Update
August 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many locations
Multiple Locations, Germany